Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion type Assertion NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_head.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion description "[Thus, attenuation of MCP-1 upregulation by inhibiting ERK phosphorylation might be a promising approach to treat CMT1X and other so far untreatable inherited peripheral neuropathies in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion evidence source_evidence_literature NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion SIO_000772 20591826 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion wasDerivedFrom befree-20150227 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.
- NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_assertion wasGeneratedBy ECO_0000203 NP644253.RANZE6Eo5Qp3-IwGQlZn5U8E22h3IkZPkfVSeIhq-mu0A130_provenance.